MedTrace Logo

Sentinel Lymph Node Detection in Patients With Stage Ib-III Melanoma Using MSOT and ICG

NCT05467137 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-07-20

No results posted yet for this study

Summary

In this study the investigators try to identify the sentinel lymph node in patients with stage Ib-III melanoma in a non-invasive manner without the use of a radioactive tracer by using the new MSOT technology.

Conditions

  • Melanoma, Stage I
  • Melanoma, Stage II
  • Melanoma Stage III

Interventions

DEVICE

MSOT

MSOT imaging (after ICG injection)

Sponsors & Collaborators

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • van Leeuwen · University Medical Center Groningen

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2022-11-30
Completion
2023-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05467137 on ClinicalTrials.gov